To view the PDF file, sign up for a MySharenet subscription.


Release Date: 06/01/2022 12:15
Code(s): ASC     PDF:  
Wrap Text
Market Update

Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
Share code: ASC
ISIN: ZAE000185005
(“Ascendis Health” or “the Company” or “the

                                                  MARKET UPDATE

Shareholders are referred to the announcement published on SENS on 30 December 2021 entitled “Extension of
Milestone Fulfilment Date and Further Cautionary Announcement” (“the 30 December Announcement”) in which they
were informed that the current Lender (being Emma Healthcare Holdings Ltd held by Blantyre Capital Limited and L1
Health GP SARL) had confirmed to the Board that it had disposed of the full amount advanced to the Group under the
Finance Documents (“the Debt”) and had agreed to transfer its rights and obligations under the Finance Documents,
including the Forbearance Agreement, to a South African consortium led by special situations investor Apex Partners
and incorporating a leading BEE health and beauty group (“the Consortium”) (“the Transaction”). They were further
informed that the achievement of the terms and milestones under the Forbearance Agreement had been extended, in
writing, to 14 January 2022, to facilitate conclusion of the transfer of the Debt to the Consortium and that it was the
Board’s aim to then agree and conclude new terms with the Consortium. The terms used in this announcement bear
the same meaning as those defined in the 30 December Announcement.

Shareholders are advised that the Company is engaging with the Consortium to facilitate the implementation of the
Transaction and has commenced negotiations regarding potential amendments to the terms of the Debt and the
Forbearance Agreement.

An announcement will be made when agreement has been reached in this regard. The Company draws shareholders’
attention to the cautionary announcement contained in the 30 December Announcement and would, once again, like to
remind shareholders that they should base their investment decisions regarding Ascendis Health shares on
announcements published by the Company itself and not on information from other sources, which may not necessarily
be accurate or based on a complete set of facts.

6 January 2022

Questco Corporate Advisory Proprietary Limited

Date: 06-01-2022 12:15:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story